Health industry should not lead the setting of priorities for the future...
Brussels, 20 September 2021 Following the preparation of the next public-private partnership – Innovative Health Initiative – health policy organisations, including several members of the Alliance,...
View ArticleHERA should prioritise the public interest, remain accountable to citizens...
HERA should prioritise the public interest, remain accountable to citizens and ensure equitable and affordable access to medical tools Brussels, 3 November 2021 Several Alliance members have sent a...
View ArticleRegional dialogue for EU activists (GSIPA2M-2021Virtual): 17 November
On Wednesday 17 November (9:30-11:30 am), the Alliance organized the regional dialogue for EU activists working on overcoming patent and other intellectual property barriers to access to health...
View ArticleGetting incentives right in the new EU pharmaceutical strategy
Brussels, 21 December 2021 Members of the Alliance have published a note today outlining key recommendations of civil society organisations for the new EU pharmaceutical strategy. A key pillar for this...
View ArticleTransparency of (real) pharmaceutical costs webinar: 18 January
On Tuesday 18 January 2022 (14:00-15:15), the Alliance co-hosted the second event of the Zooming in on Solution to the Affordability of Medicines webinar series along with Global Health Advocates (GHA)...
View ArticleCall to protect the health of people affected by the war in Ukraine
The European Alliance for Responsible R&D and Affordable Medicines calls for all parties to protect the health and welfare and guarantee access to medical tools and healthcare for all people...
View ArticleThe prevention of medicine shortages in the EU: a key priority of the...
The Members of the European Alliance for Responsible R&D and Affordable Medicines have published a note today outlining key recommendations to prevent and mitigate shortages of medicines in the...
View ArticleAlliance’s response to the European Commission’s consultation on Compulsory...
The European Alliance for Responsible R&D and Affordable Medicines welcomed the opportunity to provide feedback within this European Commission’s consultation on Intellectual property: revised...
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article